Barclays PLC Axonics, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Axonics, Inc. stock. As of the latest transaction made, Barclays PLC holds 96,378 shares of AXNX stock, worth $6.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,378

Previous 96,378 -0.0%

Holding current value

$6.84 Million

Previous $6.71 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$67.3 - $69.67 $2.17 Million - $2.25 Million	32,267 Added 50.33%	96,378 $6.71 Million
Q2 2024 Aug 14, 2024	SELL	$66.47 - $69.65 $134,535 - $140,971	-2,024 Reduced 3.06%	64,111 $4.31 Million
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $2.93 Million - $3.58 Million	-51,630 Reduced 43.84%	66,135 $4.56 Million
Q4 2023 Feb 15, 2024	BUY	$49.38 - $63.75 $2.54 Million - $3.28 Million	51,381 Added 77.4%	117,765 $7.33 Million
Q3 2023 Nov 07, 2023	BUY	$48.64 - $62.51 $2.31 Million - $2.97 Million	47,585 Added 253.13%	66,384 $3.73 Million
Q2 2023 Aug 03, 2023	SELL	$47.99 - $60.21 $292,307 - $366,739	-6,091 Reduced 24.47%	18,799 $949,000
Q1 2023 May 04, 2023	BUY	$52.6 - $67.34 $198,144 - $253,669	3,767 Added 17.83%	24,890 $1.36 Million
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $271,355 - $348,989	-4,556 Reduced 17.74%	21,123 $1.32 Million
Q3 2022 Nov 03, 2022	BUY	$57.96 - $78.12 $1.35 Million - $1.81 Million	23,216 Added 942.59%	25,679 $1.81 Million
Q2 2022 Aug 12, 2022	SELL	$39.5 - $64.42 $213,418 - $348,061	-5,403 Reduced 68.69%	2,463 $139,000
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $2.4 Million - $3.44 Million	-54,874 Reduced 87.46%	7,866 $493,000
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $1.67 Million - $2.44 Million	33,297 Added 113.09%	62,740 $3.51 Million
Q3 2021 Nov 09, 2021	BUY	$59.21 - $78.66 $1.19 Million - $1.58 Million	20,127 Added 216.05%	29,443 $1.92 Million
Q2 2021 Aug 13, 2021	SELL	$51.39 - $66.9 $834,111 - $1.09 Million	-16,231 Reduced 63.53%	9,316 $591,000
Q1 2021 May 13, 2021	BUY	$49.14 - $59.89 $736,166 - $897,212	14,981 Added 141.78%	25,547 $1.53 Million
Q4 2020 Feb 11, 2021	SELL	$42.19 - $51.5 $147,158 - $179,632	-3,488 Reduced 24.82%	10,566 $528,000
Q3 2020 Nov 12, 2020	SELL	$35.33 - $51.04 $96,238 - $139,032	-2,724 Reduced 16.24%	14,054 $718,000
Q2 2020 Aug 12, 2020	BUY	$22.91 - $39.83 $243,052 - $422,556	10,609 Added 171.97%	16,778 $588,000
Q1 2020 May 13, 2020	SELL	$16.44 - $37.73 $155,505 - $356,888	-9,459 Reduced 60.53%	6,169 $157,000
Q4 2019 Feb 10, 2020	BUY	$19.57 - $28.96 $156,814 - $232,056	8,013 Added 105.23%	15,628 $433,000
Q3 2019 Nov 14, 2019	SELL	$26.92 - $42.41 $63,100 - $99,409	-2,344 Reduced 23.54%	7,615 $205,000
Q2 2019 Aug 14, 2019	SELL	$18.54 - $40.97 $198,748 - $439,198	-10,720 Reduced 51.84%	9,959 $408,000
Q1 2019 May 15, 2019	BUY	$13.32 - $24.35 $248,857 - $454,931	18,683 Added 936.02%	20,679 $495,000
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $26,347 - $32,794	1,996 New	1,996 $31,000

Others Institutions Holding AXNX

# of Institutions

221

Shares Held

42M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account